| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.055 | 0.5 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |